232 related articles for article (PubMed ID: 20336277)
21. [Features of the development of latent autoimmune diabetes in adults (LADA)].
Timakova AA; Saltykov BB
Arkh Patol; 2019; 81(4):78-82. PubMed ID: 31407723
[TBL] [Abstract][Full Text] [Related]
22. Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain.
Mollo A; Hernandez M; Marsal JR; Esquerda A; Rius F; Blanco-Vaca F; Verdaguer J; Pozzilli P; de Leiva A; Mauricio D;
Diabetes Metab Res Rev; 2013 Sep; 29(6):446-51. PubMed ID: 23483713
[TBL] [Abstract][Full Text] [Related]
23. Diabetic autoimmune markers in children and adolescents with type 2 diabetes.
Hathout EH; Thomas W; El-Shahawy M; Nahab F; Mace JW
Pediatrics; 2001 Jun; 107(6):E102. PubMed ID: 11389300
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance in latent autoimmune diabetes of adulthood.
Behme MT; Dupre J; Harris SB; Hramiak IM; Mahon JL
Ann N Y Acad Sci; 2003 Nov; 1005():374-7. PubMed ID: 14679095
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trøndelag Health (HUNT) study.
Radtke MA; Midthjell K; Nilsen TI; Grill V
Diabetes Care; 2009 Feb; 32(2):245-50. PubMed ID: 19001190
[TBL] [Abstract][Full Text] [Related]
26. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
[TBL] [Abstract][Full Text] [Related]
27. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults.
Brophy S; Yderstraede K; Mauricio D; Hunter S; Hawa M; Pozzilli P; Schernthaner G; Schloot N; Buzzetti R; Davies H; Leslie D; Williams R;
Diabetes Care; 2008 Mar; 31(3):439-41. PubMed ID: 18083788
[TBL] [Abstract][Full Text] [Related]
28. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).
Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Sjöström J; Grönlund H; Lernmark A
Horm Metab Res; 2000 Apr; 32(4):133-8. PubMed ID: 10824708
[TBL] [Abstract][Full Text] [Related]
29. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
Morimoto J; Maruyama T; Kasuga A; Ozawa Y; Kobayashi A; Funakoshi S; Iwasaki R; Suzuki Y; Shimada A; Saruta T
Diabetes Care; 1998 Nov; 21(11):2037-9. PubMed ID: 9802771
[No Abstract] [Full Text] [Related]
30. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
Chiu HK; Tsai EC; Juneja R; Stoever J; Brooks-Worrell B; Goel A; Palmer JP
Diabetes Res Clin Pract; 2007 Aug; 77(2):237-44. PubMed ID: 17234296
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
[TBL] [Abstract][Full Text] [Related]
32. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
[TBL] [Abstract][Full Text] [Related]
33. [New-onset type 1 diabetes: what to do, differential diagnosis and prevention].
Achenbach P; Hummel M
MMW Fortschr Med; 2011 May; 153(20):45-7. PubMed ID: 21644293
[No Abstract] [Full Text] [Related]
34. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
Martinka E; Ocenásová A; Straková J; Mokán M
Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
[TBL] [Abstract][Full Text] [Related]
35. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].
Li X; Huang G; Yan X; Yang L; Zhou ZG
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1247-9. PubMed ID: 20584648
[TBL] [Abstract][Full Text] [Related]
36. [Diabetes mellitus, but which type?].
Hoekstra JB; de Koning EJ
Ned Tijdschr Geneeskd; 2004 Apr; 148(16):761-4. PubMed ID: 15129562
[TBL] [Abstract][Full Text] [Related]
37. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
Hillman M; Törn C; Thorgeirsson H; Landin-Olsson M
Diabetologia; 2004 Nov; 47(11):1984-9. PubMed ID: 15565370
[TBL] [Abstract][Full Text] [Related]
38. [Latent autoimmune diabetes in adults: an update].
Zhou ZG; Li X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):630-4. PubMed ID: 14650175
[TBL] [Abstract][Full Text] [Related]
39. Current view of diagnosis and treatment of latent autoimmune diabetes in adults.
Urbanová J; Brunerová L; Malinovská J; Pelechová B; Koberová L; Brož J
Vnitr Lek; 2021; 67(2):97-102. PubMed ID: 34074108
[TBL] [Abstract][Full Text] [Related]
40. [Clinico-immunologic aspects of diabetes mellitus].
Esenin VI; Zlobina EN; Demin IuM; Dedov II
Sov Med; 1990; (3):100-1. PubMed ID: 2195666
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
